Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06749522

Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And Cirrhosis

Fatty liver is a condition in which fat builds up in liver. it is very common health issue.it is major public health problems in the world. there is particular concern because fatty liver causes mortality among patients. The incidence and prevalence of disease vary with time. Fibrosis is thickening of connective tissues which is usually as a result of injury and long term inflammation. Cirrhosis is severe scarring of liver which is caused by long term liver damage. The scar tissue replaces healthy tissues which leads to loss of liver function. The Objective of study is to look into radiographic features of fatty liver disease. The high resolution ultrasonography will give more detailed view of disease. The study inclued 150 participants.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Fibrosis Cirrhosis Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

AL-NAWAZ HOSPITAL,Tillu Road

Saddiqabad, Punjab Province, Pakistan

About this study

The other liver conditions like fibrosis and cirrhosis are also examined and correlated with fatty liver disease. The CT and MRI are used to compare with HR ultrasonographic findings. Descriptive statistics and comparative statistics are used to interpret data.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of fatty liver (steatosis), fibrosis, or cirrhosis.
  • Patient consent to undergo imaging and participate in the study.

Exclusion criteria

  • Other Liver Diseases: Exclusion of patients with other significant liver conditions (e.g., viral hepatitis, autoimmune liver diseases) unless specified.
  • Pregnant women may be excluded due to imaging concerns.
  • Poor quality or incomplete imaging studies.
  • Presence of other severe systemic illnesses that could affect liver function or imaging.
  • Recent liver surgeries or invasive procedures that might affect imaging results

Treatment and study plan

high resolution ultrasonography

Radiation

to compare high resolution ultrasonography finings with other imaging modalities(CT and MRI)

Primary outcomes

  1. CT

    Time frame: 12 Months

    CT used for the image comparision

  2. MRI

    Time frame: 12 Months

    CT used for the image comparision

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Dec 27, 2024
Registry last updated
Dec 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.